Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine. - Wikidata - awgldk - TriplyDB

Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine.

Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine.

http://www.wikidata.org/entity/Q35155784

about

Is immunosenescence influenced by our lifetime "dose" of exercise?Long-term maintenance of diphtheria-specific antibodies after booster vaccination is hampered by latent infection with Cytomegalovirus.Cytomegalovirus infection in HIV-infected and uninfected individuals is characterized by circulating regulatory T cells of unconstrained antigenic specificity.Inflammaging decreases adaptive and innate immune responses in mice and humans Obesity decreases B cell responses in young and elderly individuals B Cell-Specific Biomarkers for Optimal Antibody Responses to Influenza Vaccination and Molecular Pathways That Reduce B Cell Function with Aging.Aging, cytomegalovirus (CMV) and influenza vaccine responses.Cytomegalovirus Vaccines: Current Status and Future Prospects.Ageing and obesity similarly impair antibody responses.Immunosenescence: limitations of natural killer cell-based cancer immunotherapy.Aging of the immune system: Focus on inflammation and vaccination.Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection.Factors affecting immune responses to the influenza vaccine.Immunity in young adult survivors of childhood leukemia is similar to the elderly rather than age-matched controls: Role of cytomegalovirus.Does Regular Exercise Counter T Cell Immunosenescence Reducing the Risk of Developing Cancer and Promoting Successful Treatment of Malignancies?Cytomegalovirus Seropositivity Predicts a Decline in the T Cell But Not the Antibody Response to Influenza in Vaccinated Older Adults Independent of Type 2 Diabetes Status.Cytomegalovirus serostatus, inflammation, and antibody response to influenza vaccination in older adults: The moderating effect of beta blockade.Immunogenicity of Varicella Vaccine and Immunologic Predictors of Response in a Cohort of Elderly Nursing Home Residents.The generation of memory B cells is maintained, but the antibody response is not, in the elderly after repeated influenza immunizations.Cytomegalovirus- and Epstein-Barr Virus-Induced T-Cell Expansions in Young Children Do Not Impair Naive T-cell Populations or Vaccination Responses: The Generation R Study.Metformin improves in vivo and in vitro B cell function in individuals with obesity and Type-2 Diabetes.Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage.Infectious reactivation of cytomegalovirus explaining age- and sex-specific patterns of seroprevalence Cytomegalovirus vaccines under clinical development Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging.The Contribution of Cytomegalovirus Infection to Immune Senescence Is Set by the Infectious Dose.Adipose Tissue Inflammation Induces B Cell Inflammation and Decreases B Cell Function in Aging.An Explorative Biomarker Study for Vaccine Responsiveness after a Primary Meningococcal Vaccination in Middle-Aged Adults.Negative Effect of Age, but Not of Latent Cytomegalovirus Infection on the Antibody Response to a Novel Influenza Vaccine Strain in Healthy Adults.How does cytomegalovirus factor into diseases of aging and vaccine responses, and by what mechanisms?CMV immune evasion and manipulation of the immune system with aging.Age-related differences in humoral and cellular immune responses after primary immunisation: indications for stratified vaccination schedules.Comparative Analysis of B-Cell Receptor Repertoires Induced by Live Yellow Fever Vaccine in Young and Middle-Age Donors The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer

P2860

Q26749901-9806ED15-D226-4DD8-8C52-5C738540E2E7 Q33837146-B8995574-CCF3-434C-9FF1-24F0C0652B84 Q33880763-09929542-F6E2-40B0-A155-D198FCA1BE58 Q36225887-B5A11099-DDC6-4AC5-AEF3-5685D93CBB6C Q36626088-E56D8DCD-5649-4253-B62C-1E5F777E14B3 Q38636645-47FFF7B7-F6F0-401A-97E6-E0D5392EEC90 Q38640148-4796C780-C34D-4F6E-9B3F-A9817F250575 Q38791353-D8246FEB-63D5-4A50-AF8F-FBBB2524206B Q38868206-A4E45F9D-A1BD-4C87-8DE6-147327BB4AE3 Q38928938-1355444E-4A9A-4EF3-B765-1ED49FE70901 Q38946555-566E0537-A998-4313-97EB-FF21B6A79A57 Q39310460-E977473E-BF95-4AFA-8CB2-35B5D5F25D6B Q39375320-6C99D607-AE5A-4C4F-8FEE-5CAA70CC4567 Q39808961-263AF18E-AD62-4ED3-A4DF-92ECE6D27572 Q40104771-C5EB7C72-08EB-4B73-9E11-45FC30830885 Q40478812-3098726B-3783-4B4B-8C5F-DE284D3B63DD Q40512629-54C71FDD-5F27-4772-BE5F-C86CF2DE419E Q40515774-0B54F1DB-B1E2-4A45-A2F6-24ACEEDAF9D6 Q40784710-25BE7D6D-C7C8-4C9B-9100-C2216087E44C Q41123313-5989F90A-7616-4BCF-ABEC-BF03595D2472 Q41445689-32FB628A-1922-40AA-A417-9FC4B32A346F Q41928464-35DDFF0E-411A-413D-B637-88723F26444E Q41929983-4A05A265-2502-462C-B489-53D37684828D Q42380888-20267DF7-3ABE-40E4-BF7A-F431712AC93C Q47140159-F11339B2-4DA3-458B-874B-4C5314BCBE9E Q47549093-E67E1EB2-1BA3-4418-A2A4-6F5D613CCADB Q48000215-9E724E00-74DF-439E-B40C-854C5CEF0CAF Q49417741-2C497A48-1CD0-4C78-9397-3CE402AD8884 Q49587964-795C4C22-23B2-451A-81C4-0FDB8691AC08 Q55315794-ED04DCE6-EEC4-4FDD-BC93-2E4DC29D9E21 Q55459013-1A0A3ACF-ACAD-4473-B77B-16B90BD803B2 Q55468883-9BDF7952-2D82-48EB-AFEC-6528B2365CAA Q57816714-7AB7B58D-CC51-45B4-A477-2DAA255965F1 Q58484770-AA6270C6-E2AF-4039-9852-56728148CF69

P2860

Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine.

http://www.wikidata.org/entity/Q35155784

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine.

@ast

Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine.

@en

type

label

Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine.

@ast

Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine.

@en

prefLabel

Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine.

@ast

Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine.

@en

P1433

Q35155784-A30FF133-BCFA-4C82-812E-5FAED13166E5

P1476

Q35155784-2682E4D5-8256-4333-9150-DA4E6D4D9D38

P2093

Q35155784-5389C142-B56F-4117-BDE9-915C3326FC8D

Q35155784-84DA0F65-8250-441E-87F6-CD4C42D144F3

Q35155784-9BFD79EA-D129-4624-9960-9F4274961A2E

Q35155784-BF0E2D25-57D1-493A-B6BB-1A46B5F31DFA

Q35155784-D19C712E-796C-46B4-A7D5-ABF963F7299F

P2860

Q35155784-04362C3E-B0F7-46C0-ACBD-B6F01CD3CD80

Q35155784-0AB9E54E-1E25-42E1-A0E0-C5BB4746BF1F

Q35155784-0C7F01E9-DA03-47E1-BBAA-120AEA766B2D

Q35155784-161AC799-1831-4516-B00E-B5E1B9B31428

Q35155784-176A11CF-95B5-45A2-A6DC-33F16C2D89CB

Q35155784-17C3AB9F-37FF-4273-8C47-4759120C4C8F

Q35155784-22AFD208-1DF1-4F4A-9E89-7BA49868A1BE

Q35155784-45A494B3-CD9B-4B78-848A-A55EB949DC9C

Q35155784-4B068138-503D-4275-9D8B-E266675C5663

Q35155784-4BEF1202-B7EA-4D88-86A0-478341770762

P304

Q35155784-CC8EB69F-FAD5-472A-8E59-92617D063B9A

P31

Q35155784-B86BACD2-D16C-4D7B-A1F8-BD1C12D55370

P356

Q35155784-AE66F93C-0245-4131-ACBA-4E2055509CF7

P407

Q35155784-2EF8FF89-5F63-4042-9E11-A9CC3B51A018

P433

Q35155784-0D92714E-5984-4600-9CC6-4D6F0DED1563

P478

Q35155784-6775042D-96D5-44D3-B567-F3B1DD8009E8

P577

Q35155784-3A87B83D-72C0-4A3F-95BE-AAB491B59FFB

P5875

Q35155784-51615C89-96FE-4C8B-8FFC-C48AC755CED6

P698

Q35155784-C65ED4BE-21DF-4F7E-9A43-0A9DF5BE87E0

P921

Q35155784-AC53CCAB-467B-4C63-A998-545462011B68

P932

Q35155784-465118BE-B339-48DA-987C-016B411E0DC1

P356

J.VACCINE.2015.01.071

P1433

P1476

Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine.

@en

P2093

Alain Diaz

http://www.w3.org/2001/XMLSchema#string

Ana Marie Landin

http://www.w3.org/2001/XMLSchema#string

Bonnie B Blomberg

http://www.w3.org/2001/XMLSchema#string

Daniela Frasca

http://www.w3.org/2001/XMLSchema#string

Maria Romero

http://www.w3.org/2001/XMLSchema#string

P2860

The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines

Inflamm-aging. An evolutionary perspective on immunosenescence

Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine.

Influenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children.

AID activity in B cells strongly correlates with polyclonal antibody affinity maturation in-vivo following pandemic 2009-H1N1 vaccination in humans.

Effects of age on H1N1-specific serum IgG1 and IgG3 levels evaluated during the 2011-2012 influenza vaccine season

Aging of the innate immune system

Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons.

Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals.

Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly.

P304

1433-1439

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2015.01.071

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272100766

http://www.w3.org/2001/XMLSchema#string

P698

25659271

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus

P932

4352374

http://www.w3.org/2001/XMLSchema#string